0001179110-15-006393.txt : 20150417 0001179110-15-006393.hdr.sgml : 20150417 20150417142322 ACCESSION NUMBER: 0001179110-15-006393 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150415 FILED AS OF DATE: 20150417 DATE AS OF CHANGE: 20150417 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BISCHOFBERGER NORBERT W CENTRAL INDEX KEY: 0001190273 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 15777536 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR STREET 2: C/O GILEAD SCIENCES, INC. CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0306 4 2015-04-15 0 0000882095 GILEAD SCIENCES INC GILD 0001190273 BISCHOFBERGER NORBERT W GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 EVP, R&D and CSO Common Stock 2015-04-15 4 M 0 70000 20.74 A 235168 D Common Stock 2015-04-15 4 S 0 10239 103.0597 D 224929 D Common Stock 2015-04-15 4 S 0 59761 103.9708 D 165168 D Non-Qualified Stock Option (right to buy) 20.74 2015-04-15 4 M 0 70000 0 D 2017-05-08 Common Stock 70000 20000 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. Sale prices reported for the transactions reported here range from $102.47 to $103.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Sale prices reported for the transactions reported here range from $103.48 to $104.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. Norbert W. Bischofberger 2015-04-17